Logo for Nirvana Life Sciences Inc.
NIRV

Nirvana Life Sciences Inc.

Status
suspended
Issued & Outstanding33,020,139
Reserved for Issuance300,000
Currency
CSE Index

About

Nirvana Life Sciences Inc.

Listing Date
March 17, 2022

Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.